Nova Mentis Life Science (NOVA.C) announced they will be organising a North American autism spectrum disorder (ASD) data bank to support the development of psilocybin-based compounds in the diagnosis and treatment of ASD. This will take place through their newly launched serotonin research center, which they established in partnership with FourthWall Testing in Florida. In … Continue reading Nova Mentis (NOVA.C) to form autism data bank at serotonin research center